FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Panel to Discuss Bacterial Pneumonia

[ Price : $8.95]

Federal Register Notice: FDAs Anti-Infective Drugs Advisory Committee will meet 12/9 to discuss developing antibacterial products ...

PDUFA Product Fee Increase Error Corrected

[ Price : $8.95]

FDA corrects earlier reported PDUFA user fees that increase product fees for FY 2010.

FDA Approves GSKs Arzerra for Chronic Lymphocytic Leukemia

[ Price : $8.95]

FDA gives accelerated approval to GlaxoSmithKlines monoclonocal antibody Arzerra for patient with chronic lymphocytic leukemia who...

Comments Sought on Cattle-Derived Product Recordkeeping

[ Price : $8.95]

Federal Register Notice: FDA seeks comments on regulations requiring records on dietary supplements, food, and cosmetics that are ...

Comments Sought on IDE Reports/Records

[ Price : $8.95]

Federal Register Notice: FDA seeks comments on investigational device exemptions reports and records.

Advisors Asked About Anthrax Drugs Efficacy

[ Price : $8.95]

FDA asks the Anti-infective Drugs Advisory Committee to comment on the efficacy and safety of Human Genome Sciences Abthrax at its...

FDA Clears Invatec Mo.Ma Device

[ Price : $8.95]

FDA clears Invatecs Mo.Ma cerebral protection device for use during carotid artery stenting.

Oxycodone IR Shortage Resolved

[ Price : $8.95]

FDA says that a shortage of oxycodone immediate release tablets has been resolved.

Grassley Wants Transparency in Advocacy Group Funding

[ Price : $8.95]

Sen. Charles Grassley asks state chapters of the National Alliance on Mental Illness to account for all industry funding they have...

FDA Amends NADA Regs

[ Price : $8.95]

Federal Register Direct final rule: FDA amends the regulations for NADAs so that the applications shall include the information as...